# Medication, Weight Gain and GI Hormones

> **NCT00384332** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 20 (actual)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** orally-disintegrating olanzapine
- **DRUG:** regular olanzapine

## Key facts

- **NCT ID:** NCT00384332
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384332, "Medication, Weight Gain and GI Hormones". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00384332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*